Homepage-old

New Studies Advance HIV Cure Science

Researchers at CROI report on post-treatment control, HIV reservoirs, and early treatment in children

Rejuvenating the Field of AIDS Research

New Mathilde Krim Fellowships Awarded

Curing HIV—
How Far Have We Come?

What are the latest updates on eradicating the virus?

Stand United in Pride

Show the world there’s nothing we can’t overcome when we stand proudly and boldly united.

amfAR, The Foundation for AIDS Research, is dedicated to ending the global AIDS epidemic through innovative research.

}

Leading the Way to a Cure

amfAR, The Foundation for AIDS Research, is one of the world’s leading nonprofit organizations dedicated to the support of AIDS research, HIV prevention, treatment education, and advocacy. Since 1985, amfAR has raised nearly $900 million in support of its programs and has awarded more than 3,800 grants to research teams worldwide.

Newest Edition of amfAR Magazine Out Now

Featuring a Q&A with Nobel laureate Dr. Drew Weissman, an interview with amfAR grantee Dr. Ya-Chi Ho, reports on our 2023 research grants, a tribute to AIDS activist Dionne Warwick—and much more.

Research Grants

amfAR utilizes formal requests for proposals to solicit grant applications for both targeted and general HIV/AIDS research. Proposals are then peer reviewed by the Scientific Advisory Committee on the basis of their relevance, scientific merit, and promise. To date, amfAR has awarded more than 3,800 grants to research teams worldwide.

Target Grants

Research Grants Awarded

See what we’ve recently supported

Request for Proposals: Target Grants
Submission Deadline: June 27, 2024

Learn how to apply

Donate to amfAR: Fuel Lifesaving Research

Make your contribution today and join the fight to #CureAIDS. Your support contributes to the advancement of amfAR’s cutting-edge HIV/AIDS research.

Show the world that a cure isn’t just possible—it’s within reach.


Stay Informed

Join our community of supporters and sign up today to
receive our monthly e-newsletter Insights and our biannual magazine Innovations.